As the GBM cells secreted MMP-2 and expressed a range of invadopodia regulator proteins, we next used a fluorescent gelatin matrix degradation assay to determine whether the GBM cell lines could form functional invadopodia. The gene discussed is MMP2; the disease is glioblastoma.